You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 10, 2025

List of Excipients in API sucralfate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing sucralfate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pharmaceutical Associates Inc SUCRALFATE sucralfate 0121-0747 FD&C RED NO. 40
Pharmaceutical Associates Inc SUCRALFATE sucralfate 0121-0747 GLYCERIN
Pharmaceutical Associates Inc SUCRALFATE sucralfate 0121-0747 METHYLPARABEN
Pharmaceutical Associates Inc SUCRALFATE sucralfate 0121-0747 SORBITOL
Pharmaceutical Associates Inc SUCRALFATE sucralfate 0121-0747 WATER
Par Pharmaceutical Inc SUCRALFATE sucralfate 0254-1011 FD&C RED NO. 40
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing sucralfate

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc sucralfate 0093-2210 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc sucralfate 0093-2210 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc sucralfate 0093-2210 STARCH, CORN
PAI Holdings LLC dba PAI Pharma sucralfate 0121-0974 BENZOIC ACID
PAI Holdings LLC dba PAI Pharma sucralfate 0121-0974 CELLULOSE, MICROCRYSTALLINE
PAI Holdings LLC dba PAI Pharma sucralfate 0121-0974 DIMETHICONE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for sucralfate

Excipient focus: ALCOHOL

Excipient focus: BENZOIC ACID

Excipient focus: BENZYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C RED NO. 30

Excipient focus: DIMETHICONE

Excipient focus: DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER

sucralfate drug variants not containing DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc sucralfate 0093-2210
Pharmaceutical Associates Inc sucralfate 0121-0747
PAI Holdings LLC dba PAI Pharma sucralfate 0121-0974
Par Pharmaceutical Inc sucralfate 0254-1011
Mylan Pharmaceuticals Inc sucralfate 0378-9205
NCS HealthCare of KY LLC dba Vangard Labs sucralfate 0615-4517
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: GLYCERIN

Excipient focus: LACTIC ACID

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHYLCELLULOSE

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 105

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links